AI Article Synopsis

  • Primary movement disorders, like restless legs syndrome and chorea gravidarum, can occur during pregnancy, with new-onset dystonia being rare but previously reported to resolve within six months post-delivery.
  • This case presents a unique instance of cervical dystonia that began during pregnancy and continued after childbirth, highlighting the potential impact of female sex hormones on movement disorders.
  • The similarities between this case and earlier reports strengthen the classification of dystonia gravidarum as a separate clinical condition.

Article Abstract

Background: Though uncommon, primary movement disorders can occur in pregnancy, the most common being restless legs syndrome and chorea gravidarum [1]. New onset dystonia in pregnancy has been reported four times previously with a resolution of symptoms within six months of delivery [2345]. Exacerbation of pre-existing movement disorders and the onset of de novo movement disorders during pregnancy support the hypothesis that female sex hormones play an important role in the regulation of basal ganglia circuitry.

Case Report: Here we describe a case of new-onset cervical dystonia during pregnancy with persistence of symptoms after delivery.

Discussion: The phenotypic overlap between this case and previously reported cases further establishes dystonia gravidarum as a distinct clinical entity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783953PMC
http://dx.doi.org/10.5334/tohm.734DOI Listing

Publication Analysis

Top Keywords

dystonia pregnancy
12
movement disorders
12
cervical dystonia
8
pregnancy
5
case onset
4
onset cervical
4
dystonia
4
pregnancy background
4
background uncommon
4
uncommon primary
4

Similar Publications

Article Synopsis
  • * Analysis involved 2,431 cases and 1,265 healthy controls, revealing that individuals with the MTHFR variant had a significantly higher risk for conditions like respiratory distress, recurrent pregnancy loss, and intellectual disabilities.
  • * The MTHFR TT-genotype specifically indicated a high risk of abnormal phenotypes, emphasizing the importance of this genetic variant in neurodevelopmental and other health-related outcomes.
View Article and Find Full Text PDF

Pregnancy in Dystonia or Tourette's Patients with DBS. Fourteen News Cases and a Review of the Literature.

Mov Disord Clin Pract

November 2024

Department of Neurology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA.

Article Synopsis
  • Deep Brain Stimulation (DBS) has shown to improve the quality of life for patients with severe forms of dystonia and Tourette's syndrome, leading to increased occurrences of pregnancy in these patients.
  • A total of 14 new pregnancies were documented in patients with either dystonia or Tourette's syndrome who have undergone DBS, alongside a review of 23 previously reported pregnancies.
  • The findings suggest that DBS is not linked to negative pregnancy outcomes, but emphasize the need for coordinated care among medical professionals and the creation of a registry to improve clinical guidelines for these patients.
View Article and Find Full Text PDF

Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder.

J Addict Med

November 2024

From the University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC (ESK); Addiction Medical Services of Wisconsin, Onalaska, WI (CWS); Health Sciences Library, University of North Carolina at Chapel Hill, Chapel Hill, NC (JLC); and Horizons Division and Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, and Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Baltimore, MD (HEJ).

Objectives: Inhalants are often used for their psychoactive effects, producing feelings of euphoria. Inhalant and solvent use is a serious public health concern, yet little is known about their effects on perinatal, fetal, and child outcomes. The aim of our review is to evaluate the impact of inhalant use by pregnant people on maternal, fetal, neonatal, and early childhood outcomes.

View Article and Find Full Text PDF

An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration.

Orphanet J Rare Dis

October 2024

Genomenon, Inc, 206 E. Huron St. Suite 114, Ann Arbor, MI, 48109, USA.

Article Synopsis
  • The study focuses on PLA2G6-associated neurodegeneration (PLAN), which includes three diseases with similar symptoms, particularly highlighting infantile neuroaxonal dystrophy (INAD), a condition that affects vision and motor skills from an early age.
  • Researchers estimated the genetic prevalence of PLAN using two approaches: collecting genetic variant data from various databases and analyzing literature to find additional relevant variants. They determined that the estimated prevalence ranges from 1 in 987,267 to 1 in 1,570,079 pregnancies.
  • The findings indicate a significant underdiagnosis of PLAN and suggest a higher presence of PLA2G6 variants in African and Asian populations, emphasizing the need for better diagnostic efforts
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!